Market News
Stay updated with the latest market trends, earnings, and economic indicators.
'Weak and lacklustre': Why Jefferies is disappointed with Wipro earnings as ADRs fall nearly 3%
Wipro’s March quarter results missed expectations, with weak revenue growth, declining profit, and soft guidance. Jefferies highlighted slowing deal momentum, weakness in BFSI and healthcare, and client-specific declines, raising concerns over near-term growth despite stable margins and a buyback announcement.
Nippon India Mutual Fund Increases Stake in Syngene International to 7.12% - scanx.trade
Nippon India Mutual Fund Increases Stake in Syngene International to 7.12%scanx.trade

Trade Setup for April 15: Nifty holds 23,500 support but bulls aim for a retest of 24,000
Wednesday's session will see stocks like ICICI Prudential Life, ICICI Prudential AMC, Just Dial react to their quarterly results, while names like LG Electronics India, Bharat Coking Coal, and Rubicon Research see their respective shareholder lock-ins end.
Market Trading Guide: Buy Ramco Systems, Natco Pharma and 2 more stocks on Wednesday for gains up to 14%
Nifty extended gains for a fourth session, confirming a breakout and positive near-term trend above key moving averages. Analysts highlight resistance at 23,200 and volatility risks from Middle East tensions, while recommending four stocks showing bullish patterns, momentum strength, and upside potential in coming weeks.
MF Favourites take a hit: 14 smallcap stocks slide up to 50% in 3 months
Despite rising mutual fund stakes, several smallcap stocks have plunged up to 47% in 2026, highlighting market uncertainty and raising questions on whether these beaten-down picks offer value or further downside.
Sun Pharmaceutical Industries Ltd eases for fifth straight session
Sun Pharmaceutical Industries Ltd is quoting at Rs 1689.8, down 0.22% on the day as on 13:19 IST on the NSE. The stock jumped 1.41% in last one year as compared to a 3.17% rally in NIFTY and a 8.74% spurt in the Nifty Pharma index.
Sensex Today Trades Lower | Nifty Below 22,700 | Kotak Mahindra & Sun Pharma Top Losers - Equitymaster
Sensex Today Trades Lower | Nifty Below 22,700 | Kotak Mahindra & Sun Pharma Top LosersEquitymaster

Nifty Pharma index drops 3% as US tariff fears hit Sun Pharma, peers
A Bloomberg report indicated that the Trump administration is planning tariffs on pharmaceutical companies that have not entered into agreements to ensure lower drug prices in the US.
Jindal Poly among 4 stocks that hit 52-week highs & rallied up to 95% in a month
The Sensex surged 568 points to close at 76,070 on Tuesday, driving a broader market rally. Four BSE 1000 stocks—Jindal Poly Films, Acutaas Chemicals, Vardhman Textiles and Ipca Laboratories—hit 52-week highs, signaling bullish momentum and potential gains ahead.

Kotak Mahindra Mutual Fund acquires stake in this recently listed healthcare stock
Kotak Mahindra Mutual Fund (KMMF) has raised its stake in the North Indian hospital network Park Medi World Limited to more than 5%. The fund purchased 175,164 shares, bringing its total ownership to 5.0393%, which necessitates a regulatory announcement in accordance with SAST regulations.
Growth Leaders: 10 midcap stocks with stellar 50%+ YoY sales gains
Several NSE midcap companies delivered strong growth in the December 2025 quarter, with sales rising over 50% year-on-year. Firms across sectors such as metals, real estate, energy and healthcare reported sharp demand-led expansion, highlighting strong business momentum and growth potential.
8 Nifty200 stocks where promoters reduced pledges in Q3FY26
Several Nifty 200 companies including Apollo Hospitals Enterprise, JSW Steel and Asian Paints reported lower promoter pledges in the December quarter, a signal of improving financial stability and stronger promoter confidence in business prospects.